We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 354 → 5 (-349)

99.54% less ownership

Funds ownership: 99.58% → 0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 29 → 0 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
344
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$822M
2
BlackRock
BlackRock
New York
-$784M
3
PCM
Pentwater Capital Management
Florida
-$500M
4
State Street
State Street
Massachusetts
-$286M
5
UBS Group
UBS Group
Switzerland
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
226
Carson Wealth (CWM LLC)
Nebraska
– -$668K -5,214 Closed
WAM
227
Wolverine Asset Management
Illinois
– -$665K -5,191 Closed
VPIM
228
Vanguard Personalized Indexing Management
California
– -$648K -5,055 Closed
Cerity Partners
229
Cerity Partners
New York
– -$645K -5,035 Closed
BPAMU
230
BTG Pactual Asset Management US
New York
– -$641K -5,000 Closed
RC
231
Rangeley Capital
Connecticut
– -$641K -5,000 Closed
X
232
Xponance
Pennsylvania
– -$637K -4,971 Closed
KCM
233
Kennedy Capital Management
Missouri
– -$620K -4,836 Closed
KOCAA
234
Knights of Columbus Asset Advisors
Connecticut
– -$609K -4,752 Closed
P
235
Pitcairn
Pennsylvania
– -$608K -4,744 Closed
Allspring Global Investments
236
Allspring Global Investments
North Carolina
– -$602K -4,687 Closed
FCM
237
Fieldview Capital Management
Michigan
– -$599K -4,673 Closed
Principal Financial Group
238
Principal Financial Group
Iowa
– -$584K -4,553 Closed
GC
239
Gilbert & Cook
Iowa
– -$569K -4,441 Closed
IB
240
Intrust Bank
Kansas
– -$562K -4,382 Closed
BC
241
Bridgefront Capital
Texas
– -$548K -4,276 Closed
BHMP
242
Bardin Hill Management Partners
New York
– -$540K -4,210 Closed
OSAM
243
O'Shaughnessy Asset Management
Connecticut
– -$528K -4,123 Closed
Mackenzie Financial
244
Mackenzie Financial
Ontario, Canada
– -$513K -4,001 Closed
CFG
245
Citizens Financial Group
Rhode Island
– -$508K -3,967 Closed
FFA
246
Farther Finance Advisors
California
– -$503K -3,928 Closed
PCM
247
Polymer Capital Management
New York
– -$454K -3,544 Closed
Wealth Enhancement Advisory Services
248
Wealth Enhancement Advisory Services
Minnesota
– -$449K -3,497 Closed
SFI
249
Susquehanna Fundamental Investments
Pennsylvania
– -$445K -3,470 Closed
HSBC Holdings
250
HSBC Holdings
United Kingdom
– -$437K -3,409 Closed
8 9
10
11 12

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.